Literature DB >> 1362509

The significance of aminopeptidases and haematopoietic cell differentiation.

K Razak1, A C Newland.   

Abstract

Aminopeptidases are a group of enzymes found on the cell surface and in the cytoplasmic compartments of many peripheral blood cell types and their progenitors. Their functional roles include the hydrolysis of several biologically active peptides and growth factors and some have proved to be of diagnostic and prognostic value in leukaemia. These enzymes may also be found in serum as a consequence of non-haematopoietic related diseases and so have been used as indicators of liver damage. Haematopoietic cells in the bone marrow go through a process of growth and differentiation before being released into the peripheral circulation where they fulfill many functional roles. The enzyme activities of some aminopeptidases have been shown to modulate the growth of these cells. In addition, the activities of these enzymes themselves can be regulated by haematopoietic growth factors. However, the mechanisms that regulate their expression and activity are not fully understood. In this report the current literature has been reviewed for evidence of expression, regulation and clinical significance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362509      PMCID: PMC7125779          DOI: 10.1016/0268-960x(92)90020-q

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  83 in total

1.  Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA.

Authors:  J Olsen; G M Cowell; E Kønigshøfer; E M Danielsen; J Møller; L Laustsen; O C Hansen; K G Welinder; J Engberg; W Hunziker
Journal:  FEBS Lett       Date:  1988-10-10       Impact factor: 4.124

Review 2.  Human aminopeptidases: a review of the literature.

Authors:  G J Sanderink; Y Artur; G Siest
Journal:  J Clin Chem Clin Biochem       Date:  1988-12

3.  Characterization of aminopeptidases in human kidney soluble fraction.

Authors:  D Mantle; B Lauffart; J McDermott; A Gibson
Journal:  Clin Chim Acta       Date:  1990-02-28       Impact factor: 3.786

4.  A human liver aminopeptidase. The amino acid and carbohydrate content, and some physical properties of a sialic acid containing glycoprotein.

Authors:  W L Starnes; F J Behal
Journal:  Biochemistry       Date:  1974-07-30       Impact factor: 3.162

5.  Beta-endorphin modulates immune functions. A review.

Authors:  E G Fischer; N E Falke
Journal:  Psychother Psychosom       Date:  1984       Impact factor: 17.659

6.  Enkephalins modify granulocyte-endothelial interactions by stimulating prostacyclin production.

Authors:  M A Boogaerts; J Vermylen; H Deckmyn; C Roelant; R L Verwilghen; H S Jacob; C F Moldow
Journal:  Thromb Haemost       Date:  1983-08-30       Impact factor: 5.249

7.  Immunological characterization of human membrane-bound arylamidases from small intestine, lung, kidney, liver, placenta and renal cell carcinoma.

Authors:  T Ito; K Hiwada; T Kokubu
Journal:  Clin Chim Acta       Date:  1980-02-14       Impact factor: 3.786

8.  Developmental regulation of c-myb in normal myeloid progenitor cells.

Authors:  S P Duprey; D Boettiger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Regulation of C-myc expression during growth and differentiation of normal and leukemic human myeloid progenitor cells.

Authors:  S D Gowda; R D Koler; G C Bagby
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

10.  Expression of myeloid differentiation antigens on normal and malignant myeloid cells.

Authors:  J D Griffin; J Ritz; L M Nadler; S F Schlossman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more
  8 in total

1.  Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.

Authors:  Jianhui Zhu; Jintang He; Yashu Liu; Diane M Simeone; David M Lubman
Journal:  J Proteome Res       Date:  2012-02-28       Impact factor: 4.466

2.  Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.

Authors:  Paola Di Matteo; Gian Luigi Arrigoni; Luca Alberici; Angelo Corti; Corrado Gallo-Stampino; Catia Traversari; Claudio Doglioni; Gian-Paolo Rizzardi
Journal:  J Histochem Cytochem       Date:  2011-01       Impact factor: 2.479

Review 3.  The neovasculature homing motif NGR: more than meets the eye.

Authors:  Angelo Corti; Flavio Curnis; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

4.  Distinct Epitopes on CD13 Mediate Opposite Consequences for Cell Adhesion.

Authors:  Claudia A Garay-Canales; Ileana Licona-Limón; Enrique Ortega
Journal:  Biomed Res Int       Date:  2018-03-29       Impact factor: 3.411

Review 5.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

6.  Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen.

Authors:  Juho J Miettinen; Romika Kumari; Gunnhildur Asta Traustadottir; Maiju-Emilia Huppunen; Philipp Sergeev; Muntasir M Majumder; Alexander Schepsky; Thorarinn Gudjonsson; Juha Lievonen; Despina Bazou; Paul Dowling; Peter O Gorman; Ana Slipicevic; Pekka Anttila; Raija Silvennoinen; Nina N Nupponen; Fredrik Lehmann; Caroline A Heckman
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 7.  Opioids, Neutral Endopeptidase, its Inhibitors and Cancer: Is There a Relationship among them?

Authors:  Magdalena Mizerska-Dudka; Martyna Kandefer-Szerszeń
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-09-06       Impact factor: 4.291

8.  In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery.

Authors:  Andrea Angelo Pierluigi Tripodi; Ivan Ranđelović; Beáta Biri-Kovács; Bálint Szeder; Gábor Mező; József Tóvári
Journal:  Pathol Oncol Res       Date:  2019-12-09       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.